News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
hows that next project "fruition" looking these daze ...?
MOO pathetic
lets hear a little chatter out there Gerry...!
MOO oye veh...
Clearly there are issues for you reading a statement and understanding it. You keep highlighting the same text that doesn't answer the question posed.
Where exactly in my post do I say anything about fake IP address, burner phones, or multiple aliases. The only thing mentioned is fake credentials (name and email address) and I stated reason why.
The rest of it you're pulling out of your ASS.
That's it. The last one. You can't provide an accurate or intelligent answer, so you keep throwing the same turd at the wall to see if it will stick. Kinda like how you make investment choices. 💩 💩 💩 None sticking for last 10 years. No zip code change for you.
here you go Joey-the-Forks-Bolo
served up to you ...
just like room service Sporto
uh oh, Gerald's "WeWorks" cubicle ...
must have gotten emptied out in a hurry - eh JOEY...?
but hey, at least you got some toilet paper left
to clean up the mess he left you...!
SMH - can't make this stuff up folks
MOO bad brains
Where exactly in my post do I say anything about fake IP address, burner phones, or multiple aliases. The only thing mentioned is fake credentials (name and email address) and I stated reason why.
The rest of it you're pulling out of your ass. And you have no clue about VPNs and IP addresses. Did your crack IT team at Dominos ever discover who was sending you pizzas? Why haven't you updated us on that?
MiamiMark (whoever the f*ck that is)... how is that relevant? Your new infatuation, perhaps? Kicked GC to the curb? Maybe it was this guy sending the pizzas?
hey JoeyForkitBolos
seems like AMBS & TOMDF has to worry about posters logging into their CC's with fake IP addy's...
burner phones, multiple aliases and phony email's - eh JOEY...?
but hey - who really knows - maybe our buddy MiamiMark can help?
SMH - lolzzz
MOO bad brains
Man Behind the Buzz
Gerald Commissiong - twice failed Stanford University "Financial Engineer" CEO hack
now looking for your money - so he can do it a 3rd time
my-o-my ... how just a few years can change things on a NY dime
especially when things are built on illusions, deceiving SH's and a Make It Up as We Go Along portfolio
SMH - only in America can you rip people off and get away with it
all that's left are broke AMBS and TOMDF SH's, and an indelible 'stain' on Wall St.
MOO sad
how's that "MANF March" doing Gerald...?
Amarantus Bioscience – Chairman’s Blog
http://www.thechairmansblog.com/amarantus-bioscience/blogs/
you know the one - AMBS CEO Blog #29
29.) MANF Begins its March Towards the Clinic
May 14th, 2015 - by Joseph Rubinfeld
Throughout my 50+ years in the biopharmaceutical industry, I have seen many programs with great promise, but very few programs that possess the fundamentally groundbreaking scientific potential to modify disease biology inherent in MANF. In the early days of Amgen, I remember EPO was Number 9 on the priority list for product development. I had to lobby extremely hard to get it moved up the ranks to Number 5 (largely due to the concept of using it in an orphan indication, replacement therapy in kidney dialysis patients). Despite the strong science behind EPO, most people in Amgen’s leadership wanted to focus on some other perceived near term potential opportunities like interlukins, inteferon, chicken growth hormone, malaria, hybridomas, etc. Without this lobbying, I am not certain we would have seen the Amgen we now know today.
I saw a similar situation with Amarantus in 2012. Towards the end of that year when I first began investing in Amarantus, and initially joined the Company as an advisor, I believed that the vast potential of the MANF program could be harnessed into a major medical breakthrough by expanding the focus of preclinical studies beyond Parkinson’s disease, and into a broader area of orphan drugs. In 2013, the Company had its first breakthrough in this area, through some groundbreaking work from the University of Miami’s Bascom Palmer Eye Institute. By demonstrating that MANF had tremendous potential to protect rods and cones in degenerative models of retinitis pigmentosa (RP), we had identified an orphan indication for which no competition existed in the market that would allow the Company to conduct some additional proof of concept work to validate prior to moving MANF into the clinic. Shortly thereafter, we generated data supporting the use of MANF in a broad range of ocular conditions, including orphan conditions such as retinal artery occlusion, as well as large indications such as glaucoma. Taken together, MANF’s potential to treat vision loss associated with a range of ophthalmological conditions alone makes it a compelling product opportunity worthy of further development.
However, we now know full well ophthalmology is just the beginning of the MANF opportunity. Either by internal development, collaboration with academics, or evaluation of the scientific literature, we now know that the MANF program’s potential expands far beyond ophthalmology, and into the areas neurology, otology, cardiology and metabolism (diabetes), among others. This vast potential for MANF is what makes today’s announcement personally so exciting for me, as the initiation of IND-enabling studies (which start with initiation of clinical grade manufacturing) has been the rate-limiting step for true product development value creation for MANF not only for the ophthalmology programs, but also the rest of the MANF pipeline. We have spent the last 12 months evaluating clinical grade material suppliers in parallel with generating the scientific and regulatory framework to support a robust IND-enabling program that will take MANF into the clinic where we can get a first glimpse of MANF’s human efficacy profile. We believe Catalent is the best clinical-grade supplier to support our development, and are extremely pleased that the process is now moving forward. Before this major step forward MANF was a wish, now it is on the path to becoming a reality.
Going forward, we will be formalizing agreements with key constituents including key opinion leaders, patient advocacy groups and regulatory experts in order to drive this program into the clinic and begin to treat patients suffering from the many afflictions MANF may impact. This is where true value will be generated and we are extremely pleased that the process has now begun.
As a Board member, I am very pleased to be helping guide the Company’s strategy forward as we have created a truly de-risked product development pipeline that can create value in many different areas, all the while providing MANF with the necessary infrastructure to be diligently moved forward without the need to rush its development and compromise its true value.
Thank you for your continued interest and support, we look forward to sharing more updates as MANF progresses towards the clinic.
Best,
Joseph Rubinfeld, PhD
Independent Director
Amarantus BioScience Holdings
maybe wrong stock board
printing $0.0002
SMH - only more bad news coming
MOO
dumptin must be out of tune
nothing to see here in AMBS
and definitely nothing to see in the insolvent, liquidated and dissolved TOMDF folks
except JOEY and his ramblin musings
MOO pathetic
BUY VOLUME...
Board moderator is back in JAIL. Seems this is a recurring thing.
AMBS TA Chart & CEO Update
AMBS on a run-away southbound out-of-control pps TRAIN WRECK these past few years...!
all under Gerald Commissiong - twice failed public securities CEO hack
and Stanford University "Financial Engineer" patented flunky
got to love the fact that Gerald Commissiong TOMDF terminated CEO has permanently moved on...
from the "DISSOLVED & OUT OF BUSINESS" TOMDF right quick
via the Israeli insolvency judicial system - in only +5 weeks time - Wowza...!
Todos Medical Announces Insolvency Proceedings in Israel
December 22, 2023 17:28 ET
https://www.globenewswire.com/en/news-release/2023/12/22/2800853/0/en/Todos-Medical-Announces-Insolvency-Proceedings-in-Israel.html
and just LOOKIE HERE - now a Managing Partner with Fortitude Advisors in Austin Tx:
even sporting a new PhD - or is that a mistake for PnD...?
if you can believe this folks - here it is - in live and living color no less:
Website
https://fortitudeadvisors.com/
Phone
512-664-2050
well Sham Wow Gerald
Psalm 23:5: "You prepare a table before me in the presence of my ENEMIES. You anoint my head with oil; my cup overflows. Surely goodness and mercy will follow me all the days of my life, and I will dwell in the house of the LORD forever.…"
sorry to say - Gerald Commissiong's been a bad man...!
just CLICKIE HERE to see that AMBS's other kissing-cousin scam TOMDF is now totally dissolved - and rightfully so:
https://todosmedical.com/about
***** BANKRUPT - INSOLVENT - LIQUIDATED - DISSOLVED - TERMINATED - OUT OF BUSINESS - CLOSED *****
got to applaud the efforts of TOMDF's Founder & former Dir., Pres. & CEO - Rami Zigdon in shutting the TOLLOVID SCAM down
Todos Medical Announces Insolvency Proceedings in Israel
December 22, 2023
https://finance.yahoo.com/news/todos-medical-announces-insolvency-proceedings-222800017.html
only took the Israeli Judge 6 weeks to put TOMDF scam to "FINAL REST"
and to exemplify Gerald Commissiong as a disgraced, twice failed CEO hack - who'll now be hung out to dry
would you or your family trust this man with your money - ever again...?
aprox. $138-Mil. trhough the TOMDF books in 5 years - what happened to all this money...?
***** INVESTIGATE GERALD COMMISSIONG - TOMDF CEO *****
"You prepare a table before me in the presence of my enemies. You anoint my head with oil; my cup overflows. Surely goodness and mercy will follow me all the days of my life, and I will dwell in the house of the LORD forever.…"
yo Lolol12
how stoopid can you be - what garbage...!
SMH - dookie in bambam is all you'll get from this ticker and its twice failed CEO hack...!
MOO shite
Todos Medical Announces Insolvency Proceedings in Israel
Press Release | 12/22/2023
https://www.wallstreet-online.de/nachricht/17658569-todos-medical-announces-insolvency-proceedings-israel
WOWZA - Tollovid is now "burnt offerings" - simultaneously TOMDF's "books are cooked"
TOMDF will soon be BK, as it teeters on the proverbial edge of unreconcilable insolvency
also with the twice failed Stanford "Financial Engineer" CEO hack Gerald Commissiong being the quintessential "link" between TOMDF and AMBS...
it stands to reason that TOMDF going BK will have a significant adverse impact on AMBS
not to believe so would only enforce ones own folly and inevitable downfall
would you trust this man with your family's hard earned honest money...?
MOO sad
yeah right - like were going to believe you ...
with your multiple aliases, burner phones, and fake IP addresses...?
ain't that right JOEY - or is it Waprcore - lolzzz...!
so many aliases - so much pumpin to do - your credibility's now permanently shot pal....!
SMH - get back on dem phones...!
MOO tout
couldn't be anymore "right as rain" then that Les
these pumpin stooges work in groups - if you get what I mean:
wink wink...!
MOO pathetic
About your assumptions...
yeah, never ever ever...
cut a financial deal with this guy:
unless you have a Grand Cayman Island storefront
and are shorting this - bigley...!
AJMHO
|
Followers
|
652
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
130501
|
|
Created
|
07/14/11
|
Type
|
Free
|
| Moderators | |||
